Cosmetic Approach for Men

  • Daniela Alves Pereira AnteloEmail author
  • Maria Claudia Almeida Issa
Reference work entry
Part of the Clinical Approaches and Procedures in Cosmetic Dermatology book series (CAPCD, volume 1)


There are many differences between male and female patients, regarding dermatological treatments and procedures, such as facial anatomy, skin biology, and aging skin process. Sex steroids modulate skin thickness, skin surface pH, wound healing, and potencial for infection and diseases. Men’s skin is usually thicker and oilier than women’s. Androgenetic alopecia is the most common cause of hair loss in men, and it usually has a considerable psychosocial impact and emotional distress. Other common problems related to hair are the pseudofolliculitis barbae and superficial folliculitis on the beard area secondary to the coiled hair shafts repenetrating the skin and to the frequent habit of shaving. All these conditions should have different approach and are going to be discussed in this chapter.


Men Cosmetic techniques Fillers Toxin Lasers; acne 


  1. Alexis A, Heath CR, Halder RM. Folliculitis keloidalis nuchae and pseudofolliculitis barbae: are prevention and effective treatment within reach? Dermatol Clin. 2014;32(2):183–91.CrossRefPubMedGoogle Scholar
  2. Ashcroft GS, Greenwell-Wild T, Horan MA, Wahl SM, Ferguson MW. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am J Pathol. 1999;155(4):1137–46.CrossRefPubMedPubMedCentralGoogle Scholar
  3. Baumann L, Brandt FS, Kane MA, Donofrio LM. An analysis of efficacy data from four phase III studies of botulinum neurotoxin type A-ABO for the treatment of glabellar lines. Aesthet Surg J/Am Soc Aesthet Plast Surg. 2009;29(6 Suppl):S57–65.CrossRefGoogle Scholar
  4. Bolognia JL. Aging skin. Am J Med. 1995;98(1A):99S–103.CrossRefPubMedGoogle Scholar
  5. Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety. Dermatol Surg : official publication for American Society for Dermatologic Surgery [et al]. 2009;35(12):1893–901.CrossRefGoogle Scholar
  6. Brauner GJ. Pseudofolliculitis barbae. In: Lebwohl MG, Heymann WR, Berth-Jones J, editors. Coulson. I. Treatment of skin disease, 3rd ed. p. 620–3. Saunders; 2010.Google Scholar
  7. Broekmans WM, Vink AA, Boelsma E, Klopping-Ketelaars WA, Tijburg LB, Van’t Veer P, et al. Determinants of skin sensitivity to solar irradiation. Eur J Clin Nutr. 2003;57(10):1222–9.CrossRefPubMedGoogle Scholar
  8. Carruthers A, Carruthers J. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids. Dermatol Surg : official publication for American Society for Dermatologic Surgery [et al]. 2005;31(10):1297–303.CrossRefGoogle Scholar
  9. Carruthers J, Carruthers A. Social significance of the eyebrows and periorbital complex. J drugs dermatol. 2014;13(1 Suppl):s7–11.PubMedGoogle Scholar
  10. Caserini M, Radicioni M, Leuratti C, Annoni O, Palmieri R. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. Int J Clin Pharmacol Ther. 2014;52(10):842–9.CrossRefPubMedGoogle Scholar
  11. Chandrashekar BS, Nandhini T, Vasanth V, Sriram R, Navale S. Topical minoxidil fortified with finasteride: an account of maintenance of hair density after replacing oral finasteride. Indian Derm online J. 2015;6(1):17–20.CrossRefGoogle Scholar
  12. Clark Jr WH, Elder DE, Guerry D, Braitman LE, Trock BJ, Schultz D, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24):1893–904.CrossRefPubMedGoogle Scholar
  13. Dao Jr H, Kazin RA. Gender differences in skin: a review of the literature. Gend Med. 2007;4(4):308–28.CrossRefPubMedGoogle Scholar
  14. de Maio M. The minimal approach: an innovation in facial cosmetic procedures. Aesthetic Plast Surg. 2004;28(5):295–300.CrossRefPubMedGoogle Scholar
  15. Dhurat R, Mathapati S. Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy. Indian J Dermatol. 2015;60(3):260–3.CrossRefPubMedPubMedCentralGoogle Scholar
  16. Dhurat R, Sukesh M, Avhad G, Dandale A, Pal A, Pund P. A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study. Int J Trichology. 2013;5(1):6–11.CrossRefPubMedPubMedCentralGoogle Scholar
  17. Duque-Estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol. 2009;61(4):707–9.CrossRefPubMedGoogle Scholar
  18. Eun HC, Kwon OS, Yeon JH, Shin HS, Kim BY, Ro BI, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252–8.CrossRefPubMedGoogle Scholar
  19. Fabbrocini G, Izzo R, Faggiano A, Del Prete M, Donnarumma M, Marasca C, et al. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol. 2016;41(1):38–42.Google Scholar
  20. Fried RG. Esthetic treatment modalities in men: psychologic aspects of male cosmetic patients. Dermatol Ther. 2007;20(6):379–84.CrossRefPubMedGoogle Scholar
  21. Gilliver SC, Ashworth JJ, Ashcroft GS. The hormonal regulation of cutaneous wound healing. Clin Dermatol. 2007;25(1):56–62.CrossRefPubMedGoogle Scholar
  22. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol. 1995;34(10):700–3.CrossRefPubMedGoogle Scholar
  23. Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol. 2006;55(6):1048–65.CrossRefPubMedGoogle Scholar
  24. Gupta AK, Lyons DC, Abramovits W. Low-level laser/light therapy for androgenetic alopecia. Skinmed. 2014;12(3):145–7.PubMedGoogle Scholar
  25. Hajheydari Z, Akbari J, Saeedi M, Shokoohi L. Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia. Indian J Dermatol Venereol Leprol. 2009;75(1):47–51.CrossRefPubMedGoogle Scholar
  26. Jang YH, Sim JH, Kang HY, Kim YC, Lee ES. The histopathological characteristics of male melasma: comparison with female melasma and lentigo. J Am Acad Dermatol. 2012;66(4):642–9.CrossRefPubMedGoogle Scholar
  27. Jones D. Gentlemen, relax: commentary on botulinum toxin in men: a review of relevant anatomy and clinical trial data. Dermatol Surg. 2013;39(10):1444–5.PubMedGoogle Scholar
  28. Keaney T. Male aesthetics. Skin Therapy Lett. 2015;20(2):5–7.PubMedGoogle Scholar
  29. Kim MK, Patel RA, Shinn AH, Choi SY, Byun HJ, Huh CH, et al. Evaluation of gender difference in skin type and pH. J Dermatol Sci. 2006;41(2):153–6.CrossRefPubMedGoogle Scholar
  30. Klein FH, Brenner FM, Sato MS, Robert FM, Helmer KA. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. An Bras Dermatol. 2014;89(6):878–84.CrossRefPubMedPubMedCentralGoogle Scholar
  31. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007;79(6 Suppl):9–25.PubMedGoogle Scholar
  32. Maio M, Rzany B. The male patient in aesthetic medicine. Berlin/Heidelberg: Springer; 2009. p. 239.CrossRefGoogle Scholar
  33. Millsop JW, Heller MM, Eliason MJ, Murase JE. Dermatological medication effects on male fertility. Dermatol Ther. 2013;26(4):337–46.CrossRefPubMedGoogle Scholar
  34. Mysore V. Mesotherapy in management of hairloss – is it of any use? Int J Trichol. 2010;2(1):45–6.CrossRefGoogle Scholar
  35. Oblong JE. Comparison of the impact of environmental stress on male and female skin. Br J Dermatol. 2012;166 Suppl 2:41–4.CrossRefPubMedGoogle Scholar
  36. Keaney TC, Alster TS. Botulinum toxin in men: review of relevant anatomy and clinical trial data. Dermatol Surg. 2013;39(10):1434–43.PubMedGoogle Scholar
  37. Pichardo R, Vallejos Q, Feldman SR, Schulz MR, Verma A, Quandt SA, et al. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol. 2009;48(1):22–6.CrossRefPubMedPubMedCentralGoogle Scholar
  38. Pontes Tde C, Fernandes Filho GM, Trindade Ade S, Sobral Filho JF. Incidence of acne vulgaris in young adult users of protein-calorie supplements in the city of Joao Pessoa – PB. An Bras Dermatol. 2013;88(6):907–12.CrossRefPubMedGoogle Scholar
  39. Quarles FN, Brody H, Johnson BA, Badreshia S, Vause SE, Brauner G, et al. Pseudofolliculitis barbae. Dermatol Ther. 2007;20(3):133–6.CrossRefPubMedGoogle Scholar
  40. Rahnayake D, Sinclair R. Male Androgenetic alopecia. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext ( South Dartmouth, MA:, Inc.; 2000.Google Scholar
  41. Rigel DS. Epidemiology of melanoma. Semin Cutan Med Surg. 2010;29(4):204–9.CrossRefPubMedGoogle Scholar
  42. Sarkar R, Jain RK, Puri P. Melasma in Indian males. Dermatol Surg. 2003;29(2):204.CrossRefPubMedGoogle Scholar
  43. Sarkar R, Puri P, Jain RK, Singh A, Desai A. Melasma in men: a clinical, aetiological and histological study. J Eur Acad Dermatol Venereol. 2010;24(7):768–72.CrossRefPubMedGoogle Scholar
  44. Sialy R, Hassan I, Kaur I, Dash RJ. Melasma in men: a hormonal profile. J Dermatol. 2000;27(1):64–5.CrossRefPubMedGoogle Scholar
  45. Simonart T. Acne and whey protein supplementation among bodybuilders. Dermatology. 2012;225(3):256–8.CrossRefPubMedGoogle Scholar
  46. Sjostrom L, Smith U, Krotkiewski M, Bjorntorp P. Cellularity in different regions of adipose tissue in young men and women. Metab clin exp. 1972;21(12):1143–53.CrossRefPubMedGoogle Scholar
  47. Tanglertsampan C. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil/0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study. J Med Assoc Thai. 2012;95(10):1312–6.Google Scholar
  48. Tsukahara K, Hotta M, Osanai O, Kawada H, Kitahara T, Takema Y. Gender-dependent differences in degree of facial wrinkles. Skin Res Technol. 2013;19(1):e65–71.CrossRefPubMedGoogle Scholar
  49. Nieschlag E, Vorona E. MECHANISMS IN ENDOCRINOLOGY: medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions. Eur J Endocrinol/Eur Fed Endocrine Soc. 2015;173(2):R47–58.CrossRefGoogle Scholar
  50. Vazquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men. A clinical and histologic study. Int J Dermatol. 1988;27(1):25–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Daniela Alves Pereira Antelo
    • 1
    Email author
  • Maria Claudia Almeida Issa
    • 2
  1. 1.Department of DermatologyHospital Universitario Pedro Ernesto/Universidade do Estado do Rio de JaneiroRio de JaneiroBrazil
  2. 2.Department of Clinical Medicine – DermatologyFluminense Federal UniversityNiteróiBrazil

Personalised recommendations